Nā Kaʻina Hana Noiʻi Peptide Hoʻohui: Hōʻike ma mua o ka nui o ka mea hoʻolako

Pane wikiwiki

A stock-price return does not set a peptide quality standard or identify why investors valued a company. This article evaluates integrated workflow evidence wi…

He aha ka loaʻa ʻana o Thermo Fisher i hoʻokahi makahiki i hōʻailona maoli e pili ana i ka ʻenehana ʻepekema ola?

he papa hoʻokolohua kahi e hoʻopili ʻia ai nā kikowaena mea kani e nā wahi lima ʻike ʻia, me hoʻokahi āpau o ke kaulahao
<papa helu ="blog-chart" kaila="laula-nui:640px;palena palena:1.5rem auto;nui-momona:12px;kiʻekiʻe laina:1.3;kala kala:hooilina"> <svg viewBox="0 0 560 380" kaila="laula-nui: 100%; kiekie: kaʻa; font-ohana: 'Inter', ʻōnaehana-ui, sans-serif; kala kala: #1e293b; --pakuhi-muted: #64748b;" kuleana="img" aria-labelledby="thermo-fisher-fy2025-segment-revenue-title thermo-fisher-fy2025-segment-revenue-desc"> <kaila> /* Hoʻokomo ka mea hāʻawi i ka pakuhi i loko o kahi iframe nona ka ʻeleʻele ʻeleʻele, a he ʻano ʻokoʻa ka iframe i ka pakuhi, no laila ua hōʻike ʻia nā pahu pahu leka me he mau papa ʻeleʻele a puni (prod 09-22). Akaka ka palapala i loko o ka iframe ma ka paʻamau; ʻO ka pena kiʻi ma ʻaneʻi e uhi ana i ke kāʻei o ka element, a ke kau ʻia ka pakuhi, ʻaʻohe mea pili kēia. E mālama i nā pale kihi ma waho o kēia poloka: ʻO kahi mea ʻano i loko o kahi SVG i hoʻokaʻawale ʻia ma ke ʻano he ʻike haole, no laila, hoʻolei kekahi bracket hele i kēlā me kēia lula i loko. */ html, kino { hope: #ffffff; palena palena: 0; } @media (makemake-hoemi-holo: hoemi) { * { hoʻouluulu: ʻaʻohe !mea nui; hoʻololi: ʻaʻohe !mea nui; } } </kaila> <pololei x="0" y="0" laula="560" kiekie="380" rx="8" hoʻopiha="#ffffff" /> <inoa id="thermo-fisher-fy2025-segment-revenue-title">Loaʻa ka loaʻa kālā ʻo Thermo Fisher FY2025</inoa> <wehewehe id="thermo-fisher-fy2025-segment-revenue-desc">Ua alakaʻi ʻo Laboratory Products a me Biopharma Services i ka loaʻa kālā o ka māhele FY2025 ma $23.984B, ma mua o Life Science Solutions ma $10.374B, Nā Mea Hana Analytical ma $8.259B a me Specialty Diagnostics ma $4.939B. Loaʻa ka loaʻa kālā ʻo Thermo Fisher FY2025. ʻikepili pae pae: Nā Huahana Lab & Biopharma 23.984; Hoʻoponopono ʻepekema Ola 10.374; Mea Hana Analytical 8.259; ʻIkepili Kūikawā 4.939.Source: Thermo Fisher Scientific, FY2025 Puka 10-K 2025.</wehewehe> <kikokikona x="280.0" y="29" heleuma kikokikona="waena" font-size="18" font-kaumaha="800" hoʻopiha="kala kala">Loaʻa ka loaʻa kālā ʻo Thermo Fisher FY2025</kikokikona> <laina x1="145" y1="298.0" x2="510" y2="298.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="243.0" x2="510" y2="243.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="188.0" x2="510" y2="188.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="133.0" x2="510" y2="133.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="78.0" x2="510" y2="78.0" hahau ="kala kala" opacity="0.08" /> <kikokikona x="136.0" y="109.8" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Nā Huahana Lab &</tspan><puna x="136.0" dy="12">Biopharma</tspan></kikokikona> <pololei x="145" y="78.0" laula="365.0" kiekie="49.0" rx="4" hoʻopiha="#f97316" /> <kikokikona x="518.0" y="109.8" font-size="11" hoʻopiha="kala kala">23.984</kikokikona> <kikokikona x="136.0" y="166.8" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">ʻIke Ola</tspan><puna x="136.0" dy="12">Nā hoʻonā</tspan></kikokikona> <pololei x="145" y="135.0" laula="157.9" kiekie="49.0" rx="4" hoʻopiha="#38bdf8" /> <kikokikona x="310.9" y="166.8" font-size="11" hoʻopiha="kala kala">10.374</kikokikona> <kikokikona x="136.0" y="223.8" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Kānāwai</tspan><puna x="136.0" dy="12">Nā mea kani</tspan></kikokikona> <pololei x="145" y="192.0" laula="125.7" kiekie="49.0" rx="4" hoʻopiha="#a78bfa" /> <kikokikona x="278.7" y="223.8" font-size="11" hoʻopiha="kala kala">8.259</kikokikona> <kikokikona x="136.0" y="280.9" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Kūikawā</tspan><puna x="136.0" dy="12">ʻIkepili</tspan></kikokikona> <pololei x="145" y="249.0" laula="75.2" kiekie="49.0" rx="4" hoʻopiha="#22c55e" /> <kikokikona x="228.2" y="280.9" font-size="11" hoʻopiha="kala kala">4.939</kikokikona> <kikokikona x="280.0" y="366" heleuma kikokikona="waena" font-size="10" hoʻopiha="kā mākou(--pakuhi-muted, kala kala)">Puna: Thermo Fisher Scientific, FY2025 Puka 10-K (2025)</kikokikona> </svg> </huahelu>

Hale Hana Ho'āʻo Peptide Hoʻoponopono hou i nā Peptides Hoʻopili ka loaʻa i kahi mea kani like ʻole, ʻoihana hoʻopau a me nā lawelawe lawelawe, ʻaʻole he pili peptide. ʻO ke kālā kālā a Thermo Fisher 2025 hōʻike makahiki hoʻohui i ka loaʻa kālā ma $44,556 miliona, i luna 4% hoike a 2% organika mai $42,879 miliona iloko 2024, me nā huahana Laboratory a me Biopharma Services ma $23,984 miliona a me Life Science Solutions ma $10,374 miliona. ʻO kāna māhele 10-K e hōʻike ana i nā mea Analytical Instruments ma $7,554 miliona a me Specialty Diagnostics ma $4,676 miliona, ʻoiai ka moʻolelo ma ka waihona hoʻokahi e hāʻawi $8.259 piliona a $4.939 piliona; hui ka papaʻaina i ka huina hoʻokahi $(2,033) hoʻohana ʻia nā miliona o ka hoʻopau ʻana, no laila e haʻi i ka papaʻaina.

Nā Kaʻina Hana Noiʻi Peptide Hoʻohui: Hōʻike ma mua o ka nui o ka mea hoʻolako

ʻO ka mea hoʻokele ulu i hōʻike ʻia he hiki i luna a i lalo. ʻO ka laina bioproduction ma ka waihona like hiki aku $3,200 miliona iloko 2025, i luna $548 miliona, a ʻo ka bioproduction i alakaʻi ai i ka ulu ʻana o nā ola ʻepekema ʻo Life Science Solutions; ʻO ka māhele kūkākūkā ma ka 10-K kahi bioproduction ma waena o ʻekolu mau ʻoihana mua i kēlā māhele a hoʻomaopopo i ka Sepatemaba 1, 2025 ka loaʻa ʻana o ka Solventum kānana a me ka ʻoihana hoʻokaʻawale. He ʻaoʻao lawelawe ka ʻōlelo hoʻohui: ʻO ka wehewehe ʻana i nā ʻāpana i loko o ka waiho ʻana e wehewehe i nā huahana Laboratory a me nā lawelawe Biopharma e hāʻawi ana "kokoke i nā mea āpau e pono ai no ka hale hana" a me ka noiʻi lapaʻau ma ke ʻano he "hoʻopiha piha., hoʻomohala hoʻomohala hoʻohui,” a Ua wehewehe ka hoʻokele i kāna mōhai ʻo Accelerator e like me CDMO a me CRO ma ka 2026-01-29 kahea. ʻAʻohe mea i loko o kahi heluhelu kikokikona piha o ka waiho ʻana e kākoʻo i ka heluhelu ʻana i ka hoʻihoʻi ʻana ma ke ʻano he peptide-service consolidation, ʻo ia ka palena pono o ka hōʻailona.

He aha ka hana noiʻi peptide i hoʻohui ʻia, a ma hea ka manawa a me ka hana hou ʻana o nā mea kūʻai aku?

ʻAʻole ʻōlelo kēlā hōʻailona portfolio e pili ana i ke kaulahao e hele ai kahi peptide lot, no laila e hoʻomaka me ke ʻano o ke kaulahao. ʻO kahi kaʻina hana noiʻi peptide i hoʻohui ʻia he hoʻokahi mau, hoʻopaʻa ʻia ka moʻolelo mai ka hoʻolālā ʻana ma o ka synthesis, ka hoomaemae ana, ʻano a me ka hoʻoholo hoʻokuʻu, no laila hiki ke huli ʻia kekahi hailona i ke kaʻina pololei a me ke ʻano i hana ai. Hōʻike ʻia ke kumukūʻai o ke kaulahao haki i ka peptide synthesis a me ka hoʻomaʻemaʻe lima, kahi e hele ai kahi ʻano a i ʻole kahi kaʻina i ka palena ʻoihana. I Q2(R2) koi ʻia ka ʻāpana a i ʻole ka hōʻoia piha ʻana o nā hiʻohiʻona i hoʻopili ʻia a / a i ʻole ka hoʻohālikelike ʻana i nā laʻana i hōʻike ʻia ma waena o ka hoʻomaka ʻana a me ka loaʻa ʻana o nā laboratories i ka wā e neʻe ai kahi kaʻina hana hōʻoia., me ka nui i hoaponoia e ka hana, ka hoʻololi a me ka ʻike mua. ʻO ka matrix hōʻoia ma ICH Q2(R2) hana i ka hopena paʻa: pono ka ʻike i ka kikoʻī wale nō, ʻoiai ka maʻemaʻe a me ka hoʻāʻo ʻana e lawe kēlā me kēia i kā lākou mau hiʻohiʻona ponoʻī, no laila hiki mai kahi ala hoʻomaʻemaʻe HPLC i hoʻololi ʻia me ka hana i hoʻopili ʻia.

Nā Kaʻina Hana Noiʻi Peptide Hoʻohui: Hōʻike ma mua o ka nui o ka mea hoʻolako

ʻO ka mea e pono ai kēlā me kēia pae i mua e wehewehe ʻia ma ka hopena hoʻomaka. ʻO ke alakaʻi alakaʻi EMA ma nā peptides synthetic Pono e hoʻopaʻa ʻia nā derivatives amino acid i pale ʻia no ka helehelena, ʻike ʻike, haumia pili (enantiomeric, diastereomeric, nā ʻakika amino pale ʻole, dipeptides, β-alanyl haumia), nā haumia ʻē aʻe a me ka hoʻāʻo ʻana, me ka loiloi koʻikoʻi e hiki ai i nā mea haumia hoʻomaka ke hoʻopilikia i ka ʻaoʻao haumia o ka peptide. Hoʻokahi moʻolelo ʻenehana a CDMO no ke kumu e nalowale ai ka hoʻololi ʻana i nā inoa paheʻe, nā ʻokoʻa lako a me ka laka kaʻina hana lohi, a ʻōlelo ʻo nā kaʻina hana "hiki ke lohi nui a i kekahi mau manawa, ʻaʻole hoʻomaka"; ʻAʻohe kumu i loko o kēia pūʻulu e hoʻohālikelike i kahi helu hana hou peptide-specific, no laila e mālama i kekahi pākēneka i hōʻike ʻia iā ʻoe me ka hōʻoia ʻole.

Ki Takeaway: ʻO ka pūʻulu moʻolelo e hopu ana i ka hemahema o ke ala ala he kahua kahua: mana kaʻina, kahua hoʻololi a me kemika, hailona, ʻano ID, kolamu, gradient, ka lōʻihi nalu a me ka maʻamau kuhikuhi, pili kēlā me kēia i ka hoʻoholo hoʻokuʻu i kākoʻo ʻia.

Nā Kaʻina Hana Noiʻi Peptide Hoʻohui: Hōʻike ma mua o ka nui o ka mea hoʻolako

He aha ka mea e pono ai e lawe ʻia kahi pūʻolo data peptide pili, a pehea ka maemae, ʻike ʻike, maʻiʻo peptide net, ʻokoʻa ka counterion a me ke kūpaʻa e like me nā ʻano hoʻokuʻu?

he ʻano HPLC me ka piko peptide nui a me kahi poʻohiwi haumia co-eluting liʻiliʻi i kaha ʻia e kūʻē i ka 0.1, 0.5 a 1.0

Nā paepae haumia EMA peptide Nā paepae haumia EMA peptide: waiwai no ka Hoike, E hoomaopopo, Kupono. Nā paepae haumia EMA peptide. ʻikepili lollipop: Hōʻike 0.1; E hoomaopopo 0.5; Pono 1.Source: EMA synthetic peptides alakaʻi 2025. Nā paepae haumia EMA peptide Hōʻike 0.1 E hoomaopopo 0.5 Kupono 1 Puna: EMA synthetic peptides alakaʻi (2025)

He mea koʻikoʻi kēlā mau kahua inā pane kēlā me kēia i kahi nīnau hoʻokuʻu ʻokoʻa, ʻaʻohe helu hoʻokahi e pani i kekahi. ʻO ke alakaʻi alakaʻi EMA ma nā peptides synthetic hoʻonohonoho i nā paepae haumia pili peptide i 0.1% hōʻike, 0.5% hoomaopopo a 1.0% kūpono, koi i nā ʻano haumia hiki ke hoʻokō i ka 0.1% paepae hōʻike, pili i ka 1.0% paepae hōʻoia i ka hui ʻana i nā haumia i ʻike ʻia ma ke kiʻekiʻe hoʻokahi, a paipai i ʻelua mau ʻano hana orthogonal no ka ʻike ma ka hoʻokuʻu ʻana. ʻO ka lā kūpono o ke alakaʻi like 1 Iune 2026, aponoia e CHMP ma 1 Kekemapa 2025 a me CVMP ma 4 Kekemapa 2025.

Hoʻokuʻu ʻano

Nīnau ia pane

Hoʻokumu ʻana i ke ʻano

Kūlana hoʻomalu

Maemae

Pehea ka nui o ka haumia pili peptide Nā Peptides Kuʻu Pūnaewele aia i kēia manawa, a aia ma luna 0.1%?

HPLC me kahi hōʻike hōʻoia i hōʻoia ʻia i 0.1%

Nā paepae EMA

ʻIkepili

ʻO ke kaʻina ka mea i kuhikuhi ʻia?

ʻElua mau ala orthogonal (MS, palapala palapala peptide, ka nānā ʻana i ka ʻakika amino, NMR) Hoʻoponopono Peptide

EMA gu Kūʻai Kūʻai Kūʻai Peptides manaʻo kuhi

ʻO ka maʻiʻo peptide pūnaewele

Pehea ka nui o ka waihona peptide i loko o ka vial?

ʻIke ʻia e LC, kālailai elemental, ka nānā ʻana i ka ʻakika amino, Kjeldahl nitrogen a i ʻole qNMR

ʻO nā koi hoʻāʻo i kēlā alakaʻi

Kūʻē

ʻO ke ʻano o ka paʻakai, a ma ka palena luna i hoaponoia?

ʻO ka ʻike counter-ion a me ka hoʻāʻo maʻiʻo

ʻO ka ʻāpana counter-ion o ke alakaʻi

Paʻa

Ke hoʻokō mau nei ka hailona i nā kikoʻī i kona manawa i hāʻawi ʻia? Polypeptide

Wā lōʻihi, nā haʻawina waena a me ka wikiwiki

I Q1A(R2); I Q5C

ʻO Counterion kahi e haki mālie ai ke kūlike o ka peptide lot-to-lot. ʻO nā koi hoʻāʻo i kēlā alakaʻi hōʻike hōʻike ma ka counter-ion-free, kumu anhydrous a wehewehe i ka ikaika e like me ka peptide base mass, a ʻo ka ʻāpana counter-ion o ke alakaʻi e koi ai i ka ʻike kūʻē i ka ion a me ka ʻike me ka palena luna kūpono, ʻO ka ʻike maʻamau ka acetate akā hiki ke trifluoroacetate a i ʻole chloride. ʻO ka loiloi counter-ion o ke alakaʻi ʻo ia hoʻi ʻelua mau puʻupuʻu i ka maʻemaʻe HPLC hoʻokahi hiki ke ʻokoʻa i ka peptide hiki ke hoʻopakele..

Hoʻolālā i nā haʻawina kūpaʻa no ka mea, pae hoʻohana a hoʻomohala. ʻAʻole hoʻokau like nā laʻana hoʻopaʻa inoa Q1A, ka hoʻolālā waena a me ka wikiwiki i kēlā me kēia peptide noiʻi a i ʻole ke kūlana mālama.

E hoʻohana i ka K/M wale nō ma kāna huahana kūpono a me ka pōʻaiapili ala, me nā ʻāpana dosis paʻa. ʻO ka mea maʻamau 5 ʻO ka waiwai EU/kg no ka hoʻohana makua ʻole intrathecal i ʻōlelo ʻia ʻaʻole ia he hōʻailona ākea no kēlā me kēia ala a i ʻole ka hoʻokolohua hoʻokolohua.. E hōʻike i ke kūpono endotoxin i kahi e pono ai ka hoʻāʻo.

⚠️ ʻŌlelo Aʻo: ʻO nā mea i manaʻo ʻia no ka in vivo a i ʻole ka hoʻohana lāʻau lapaʻau e lawe i nā koi ʻē aʻe ma mua o nā ʻano i luna. E hōʻoia i ka laulā me kāu hana hoʻoponopono a me ka maikaʻi ma mua o ka hilinaʻi ʻana i kekahi pūʻolo mea hoʻolako.

Pehea mākou e hoʻohana ai i kēia ma MOL Changes, ka mea hoʻopuka o kēia alakaʻi. ʻO kā mākou hana hoʻāʻo peptide e uhi i nā kikoʻī nui no ka ʻike, HPLC no ka pakeneka maemae, pH, ka hoʻoholo ʻana i ka ʻike peptide a me ka hoʻāʻo endotoxin, a me nā kauoha me HPLC, Nā hōʻike MS a me ka pH, no laila hiki i kēlā mau ʻano hoʻokuʻu ke hōʻea ma ke ʻano he helu maʻemaʻe hoʻokahi. ʻO ka mea a mākou e hana ʻole ai ʻo ia ke hōʻoia i ka paʻa: ʻaʻohe palapala mea kūʻai aku a mākou e paʻa nei i kahi papahana kūpaʻa, no laila e noho mau ana ka ʻikepili mālama ola a me ka hoʻohaʻahaʻa i ke kuleana o ka mea heluhelu, ʻākoakoa ʻia i kā lākou hoʻopaʻa ʻana me kekahi mea hoʻolako, komo pū kā mākou.

He aha ke kānāwai hoʻoholo e hoʻopili ai kahi hui e hoʻoholo inā pili maoli kahi peptide workflow a me nā mea hoʻolako?

Me kēlā mau ʻano i wehewehe ʻia, ʻo ka hoʻāʻo ʻana inā paha e lawe maoli ka mea hoʻolako iā lākou, no laila e hoʻopili i ʻelima mau nīnau i kahi pūʻolo maoli a kū i ka nīnau mua i hāʻule. Ka mua, hana ʻia ka mana o ka pūʻolo, kahua hoʻololi a me kemika, a hailona ma ka palapala like me ka hopena? Ka lua, Aia ka ʻike ma luna o ʻelua mau ala orthogonal, e like me ke alakaʻi alakaʻi EMA ma nā peptides synthetic paipai no ka hookuu ana? Ke kolu, Loaʻa i ke ʻano hoʻomaʻemaʻe kahi hōʻike hōʻoia ʻia a hiki i ka 0.1% malalo I Q2(R2), ma mua o ka palena maʻamau? Ka ʻehā, ʻo ia ka ʻike kūʻē a me ka ʻike, Ua hōʻike ʻia ka ʻike wai a me ka peptide net, ma ka pauku counter-ion o ke alakai? Ka lima, ua mākaukau nā moʻolelo uila e nānā?

ʻO kēlā nīnau hope loa ke kaumaha hoʻoponopono. ʻO ke alakaʻi pono o ka ʻikepili GxP o MHRA wehewehe ʻo ALCOA ma ke ʻano he Attributable, Legible, ʻO kēia manawa, Kumu a pololei, me ka "+" hoʻohui Complete, Kūlike, Hoʻomau a Loaʻa, a ʻōlelo ʻia ʻaʻohe ʻokoʻa o ka manaʻo i kēlā me kēia acronym i hoʻohana ʻia. 21 CFR 11.10(e) pono palekana, hana kamepiula, ʻO nā ala hoʻokele manawa i hoʻopaʻa ʻia ʻaʻole i hūnā i ka ʻikepili mua a mālama ʻia ma ka liʻiliʻi loa e like me ka moʻolelo o ke kumuhana., oiai 11.10(a), (c) a (d) uhi i nā ʻōnaehana hōʻoia, ka hoʻihoʻi ʻana a me ka mana ʻae. 21 CFR 11.50 a 11.70 koi i kēlā me kēia moʻolelo i pūlima ʻia e hōʻike i ka inoa i paʻi ʻia, lā a me ka manawa, a me ke ano, me ka pūlima i hoʻopili ʻia no laila ʻaʻole hiki ke hoʻopau ʻia. Mahele o FDA 11 ʻIke maopopo ʻia ke alakaʻi ākea ʻaʻole e wehe ka paʻi pepa i ke kuleana inā ʻo ka palapala uila ka mea e hilinaʻi ai ka ʻoihana..

He kūlana ka ʻae ʻana o ka mea hoʻolako, 'a'ole 'akomi. 21 CFR 211.84 hiki i ka mea hoʻolako hōʻike no ka nānā ʻana ma kahi o ka maʻemaʻe piha, ka ikaika a me ka hoʻāʻo maikaʻi wale nō inā hana ʻia ma kahi o hoʻokahi hōʻike ʻike kikoʻī a hoʻokumu ka mea hana i ka hilinaʻi o ka mea hoʻolako ma o ka hōʻoia ʻana i nā manawa kūpono.. I Q9(R1), pono 26 Iulai 2023, hoʻopaʻa i ka mākaʻikaʻi o ka mea kūʻai aku i ka loiloi pilikia a ʻōlelo ʻo ia ʻaʻole pono nā kumu waiwai e hōʻoia i ka hana haʻahaʻa. ʻO kēia nā pae hoʻohālikelike loiloi peptide e hoʻokaʻawale i kahi mea hoʻolako pili mai kahi wikiwiki.

No ke kōkua: E holo i nā nīnau ʻelima e kūʻē i hoʻokahi palapala hōʻoia o ka loiloi i kēia pule. ʻO ka "ʻaʻole" ma ka nīnau hoʻokahi a ʻelua ʻaʻole hiki ke hilinaʻi ʻia ke koena o ka pūʻolo no kahi hoʻoholo i hoʻoponopono ʻia.

Nīnau pinepine

ʻO ka hana kaʻana like ʻo Thermo Fisher ke ʻano o ka hoʻohui ʻana o nā lawelawe peptide?

ʻAʻole. ʻO ke kālā kālā a Thermo Fisher 2025 hōʻike makahiki ʻAʻohe ʻōlelo o "peptide" a i ʻole "peptides maʻamau,” a ʻo ka mea hoʻokele ulu i hōʻike ʻia i loko o Life Science Solutions he bioproduction ma $3,200 miliona, i luna $548 miliona. ʻO nā helu hoʻihoʻi he ʻikepili mākeke i hāʻawi ʻia e ka mea kākau e ʻokoʻa ma ke kumu a me ka lā, ʻAʻole kahi ʻōlelo e pili ana i ka hiki ke peptide.

Hiki i nā ʻāpana peptide ʻelua ma ka hoʻomaʻemaʻe HPLC hoʻokahi ke hāʻawi i nā nui o ka peptide?

ʻAe. ʻO nā koi hoʻāʻo ma ka alakaʻi alakaʻi EMA hōʻike hōʻike ma ka counter-ion-free, kumu anhydrous a wehewehe i ka ikaika e like me ka peptide base mass, a pono e hoʻomalu ʻia nā ʻike counter-ion me ka palena kiʻekiʻe. No laila, ʻokoʻa nā ʻāpana ʻelua i ka maʻemaʻe i ʻōlelo ʻia i ka peptide hiki ke hoʻouna ʻia ke helu ʻia ka counterion a me ka wai..

He palapala hōʻoia o ka hoʻolako ʻana i lawa e hoʻokuʻu i kahi peptide lot?

Kūlana wale nō. 21 CFR 211.84 ʻae i ka ʻae ʻana i kahi hōʻike hoʻopuka no ka nānā ʻana ma kahi o ka hoʻāʻo piha inā hana ʻia hoʻokahi hōʻike ʻike kikoʻī a hōʻoia ʻia ka hilinaʻi o ka mea kūʻai aku i nā manawa kūpono.. ʻO ka hoʻāʻo ʻike a me ka wā hōʻoia ʻo ia nā wahi mana kūpono.

Hana i nā paepae haumia EMA peptide e pani i nā palena ICH Q3A?

ʻAe, no nā peptides synthetic. ʻO ke alakaʻi alakaʻi EMA ma nā peptides synthetic ʻōlelo ʻia ua kāpae ʻia nā peptides synthetic mai ICH Q3A/VICH GL10 a me kēlā Ph. Eur. Pili nā paepae pili i ka peptide: hoike maluna 0.1%, hoʻomaopopo ma luna 0.5% a kūpono i luna 1.0%.

Ka hopena

ʻO ka lawe ʻana i loaʻa, ʻo ia ka pilina o ka moʻolelo, ʻaʻole i ka nui o ka mea hoʻolako. Hoʻopili ʻia kahi kaʻina hana i ka wā o ka mana kaʻina, kemika hoʻololi, hailona, ʻano ID, kolamu, gradient, hele pū me ka maʻemaʻe ka lōʻihi nalu a me ka maʻamau kuhikuhi, ʻike ʻike, ʻupena maʻiʻo, counterion a me nā hopena paʻa, a i ka wā e hoʻokō ai kēlā mau moʻolelo i ke ala loiloi a me nā koi hoʻopili pūlima o 21 CFR 11.10(e) a 21 CFR 11.50 a 11.70. ʻO ka ʻanuʻu aʻe, ʻo ke noi ʻana i kahi laʻana i hoʻopili ʻia pūʻolo ʻikepili no hoʻokahi kaʻina ʻelele mai kāu mea kūʻai aku a i ʻole ka mea hoʻolako moho a holo i nā nīnau ʻelima e kūʻē iā ia.; ʻO kahi pūʻolo i hiki ʻole ke nīnau i hoʻokahi a i ʻole ʻelua ʻaʻole ia he ʻāpana palapala akā he pilikia reproducibility āu i ana i kēia manawa.

Hōʻike ka mea hoʻopuka: Hāʻawi ʻo MOL Changes i nā lawelawe peptide a he hoihoi koʻikoʻi i kēia kumuhana. ʻO nā lālā lawelawe a me nā ʻōlelo hiki ke koi i nā mea hoʻolako; ʻO ka loaʻa a me ka hana ʻana no kahi kūkulu kikoʻī e koi i nā hōʻike kikoʻī o ka papahana.

Xiaoxia Chen

Xiaoxia Chen

Laau Laau Hou R&D ʻenehana Kaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.

Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā ​​peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana